Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Correction: Oncogenic EME1 promotes tumor progression and immune modulation in human cancers with therapeutic targeting potential.
Journal: Discover oncology
Published: October 23, 2025
Exploring Ventilator-Associated Pneumonia: Microbial Clues and Biomarker Insights from a Retrospective Study.
Journal: Medicina (Kaunas, Lithuania)
Published: June 29, 2024
Oncogenic Potential of Replication Factor C Subunit 4: Correlations with Tumor Progression and Assessment of Potential Inhibitors.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 10, 2023
Cyclin Dependent Kinase Inhibitor 2A Genetic and Epigenetic Alterations Interfere with Several Immune Components and Predict Poor Clinical Outcome.
Journal: Biomedicines
Published: July 13, 2023
Integration of Ultrastructural and Computational Approaches Reveals the Protective Effect of Astaxanthin against BPA-Induced Nephrotoxicity.
Journal: Biomedicines
Published: January 01, 2023
Integration of immunoinformatics and cheminformatics to design and evaluate a multitope vaccine against Klebsiella pneumoniae and Pseudomonas aeruginosa coinfection.
Journal: Frontiers in molecular biosciences
Published: December 14, 2022
Targeting Cancer Stem Cells as the Key Driver of Carcinogenesis and Therapeutic Resistance.
Journal: International journal of molecular sciences
Published: October 24, 2022
Assessment of RACGAP1 as a Prognostic and Immunological Biomarker in Multiple Human Tumors: A Multiomics Analysis.
Journal: International journal of molecular sciences
Published: October 18, 2022
Last Updated: 09/26/2026